Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Gilead Sciences Inc | 46 |
| 2 | Life Technologies Corp | 40 |
| 3 | Cerus Corp | 36 |
| 4 | BTG International Ltd | 31 |
| 5 | Epoch Biosciences Inc | 28 |
| 6 | Anacor Pharmaceuticals LLC | 19 |
| 7 | Biosearch Technologies Inc | 18 |
| 8 | Applied Biosystems Inc | 13 |
| 9 | ELITechGroup MDx LLC | 13 |
| 10 | Genelabs Technologies Inc | 13 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 483 |
| 2 | A61P | Therapeutic activity (drug indications) | 471 |
| 3 | C07D | Heterocyclic compounds | 318 |
| 4 | C12Q | Measuring/testing involving enzymes | 287 |
| 5 | C12N | Microorganisms, enzymes | 139 |
| 6 | Y02A | Climate change adaptation | 120 |
| 7 | C07H | Sugars and derivatives | 108 |
| 8 | G01N | Investigating / analysing materials | 98 |
| 9 | C07K | Peptides | 77 |
| 10 | C07C | Acyclic and carbocyclic compounds | 71 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Trypanosoma species research and implications | 6 |
| 2 | DNA and Nucleic Acid Chemistry | 3 |
| 3 | Renin-Angiotensin System Studies | 2 |
| 4 | Vector-borne infectious diseases | 2 |
| 5 | Agriculture and Rural Development Research | 1 |
| 6 | Bacteriophages and microbial interactions | 1 |
| 7 | Glaucoma and retinal disorders | 1 |
| 8 | Microbial metabolism and enzyme function | 1 |
| 9 | Pharmacological Effects and Assays | 1 |
| 10 | Pulmonary Hypertension Research and Treatments | 1 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | F. W. Jennings | University of Glasgow | 12 |
| 2 | Anderson J. Ferreira | Universidade Federal de Minas Gerais | 11 |
| 3 | Aleksandro S. Da Silva | Universidade do Estado de Santa Catarina | 9 |
| 4 | Anil Bhanudas Gaikwad | Birla Institute of Technology and Science, Pilani | 6 |
| 5 | Erich Zweygarth | Freie Universität Berlin | 6 |
| 6 | Ikuo Igarashi | Obihiro University of Agriculture and Veterinary Medicine | 6 |
| 7 | A. S. Peregrine | International Centre of Insect Physiology and Ecology | 5 |
| 8 | Akira Arakawa | Osaka Prefecture University | 5 |
| 9 | Andrew S. Peregrine | International Centre of Insect Physiology and Ecology | 5 |
| 10 | Burkhard Bauer | Freie Universität Berlin | 5 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Defining the drug incorporation properties of PLA–PEG nanoparticles | 2000 | 222 | Nanoparticle-Based Drug Delivery |
| Trypanosomiasis by Trypanosoma vivax in cattle in the Brazilian semiarid: Description of an outbreak and lesions in the nervous system | 2006 | 200 | Trypanosoma species research and implications |
| Pharmacology of diminazene: a review | 1993 | 192 | Trypanosoma species research and implications |
| Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models | 2013 | 175 | Pulmonary Hypertension Research and Treatments |
| Lipid-Drug-Conjugate (LDC) Nanoparticles as Novel Carrier System for the Hydrophilic Antitrypanosomal Drug Diminazenediaceturate | 2002 | 173 | Lipid Membrane Structure and Behavior |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of Berenil?
What are the primary research topics associated with Berenil in the scientific literature?
Which organizations hold the most patents related to Berenil?
What notable research papers have been published about Berenil's properties and applications?
What patent classification categories dominate the Berenil patent landscape?